33423870|t|Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.
33423870|a|OBJECTIVE: Since apathy increases in prevalence with severity of dementia pathology, we sought to distinguish concomitant neurodegenerative processes from brain differences associated with apathy in persons with mild cognitive impairment (MCI) and Alzheimer's Disease (AD). We examined relative structural brain differences between case-control matched cognitively impaired patients with and without apathy. DESIGN: Cross-sectional case-control study. SETTING: Fifty-eight clinical sites in phase 2 of the AD Neuroimaging Initiative across the United States and Canada. PARTICIPANTS: The >= 55 years of age with MCI or AD dementia and no major neurological disorders aside from suspected incipient AD dementia. Participants with apathy (n=69) were age-, sex-, apolipoprotein E epsilon4 allele carrier status-, Mini-Mental State Exam score-, and MCI or AD dementia diagnosis-matched to participants without apathy (n=149). INTERVENTIONS: The 3-tesla T1-weighted MRI scan and neurocognitive assessments. Using the Neuropsychiatric Inventory apathy domain scores, participants were dichotomized into a with-apathy group (score >= 1) and a without-apathy group (score = 0). MEASUREMENTS: Cortical thicknesses from 24 a priori regions of interest involved in frontostriatal circuits and frontotemporal association areas. RESULTS: False-discovery rate adjusted within-group comparisons between participants with apathy and participants without apathy showed thinner right medial orbitofrontal (mOFC; meandifference(MD)+-standarderrorofMD(SE)=-0.0879+-0.0257mm; standardizedMD(d)=-0.4456) and left rostral anterior cingulate (rACC; MD+-SE=-0.0905+-0.0325mm; d=-0.3574) cortices and thicker left middle temporal cortices (MTC; MD+-SE=0.0688+-0.0239mm; d=0.3311) in those with apathy. CONCLUSION: Atrophy of the right mOFC and left rACC and sparing of atrophy in the left MTC are associated with apathy in cognitively impaired persons.
33423870	37	57	Cognitively Impaired	Disease	MESH:D003072
33423870	58	66	Patients	Species	9606
33423870	84	90	Apathy	Disease	
33423870	109	115	apathy	Disease	
33423870	157	165	dementia	Disease	MESH:D003704
33423870	281	287	apathy	Disease	
33423870	309	329	cognitive impairment	Disease	MESH:D003072
33423870	331	334	MCI	Disease	MESH:D060825
33423870	340	359	Alzheimer's Disease	Disease	MESH:D000544
33423870	361	363	AD	Disease	MESH:D000544
33423870	445	465	cognitively impaired	Disease	MESH:D003072
33423870	466	474	patients	Species	9606
33423870	492	498	apathy	Disease	
33423870	598	600	AD	Disease	MESH:D000544
33423870	662	674	PARTICIPANTS	Species	9606
33423870	704	707	MCI	Disease	MESH:D060825
33423870	711	722	AD dementia	Disease	MESH:D000544
33423870	736	758	neurological disorders	Disease	MESH:D009461
33423870	790	801	AD dementia	Disease	MESH:D000544
33423870	803	815	Participants	Species	9606
33423870	821	827	apathy	Disease	
33423870	852	868	apolipoprotein E	Gene	348
33423870	937	940	MCI	Disease	MESH:D060825
33423870	944	955	AD dementia	Disease	MESH:D000544
33423870	977	989	participants	Species	9606
33423870	998	1004	apathy	Disease	
33423870	1131	1137	apathy	Disease	
33423870	1153	1165	participants	Species	9606
33423870	1196	1202	apathy	Disease	
33423870	1236	1242	apathy	Disease	
33423870	1480	1492	participants	Species	9606
33423870	1498	1504	apathy	Disease	
33423870	1509	1521	participants	Species	9606
33423870	1530	1536	apathy	Disease	
33423870	1580	1584	mOFC	Disease	
33423870	1860	1866	apathy	Disease	
33423870	1880	1887	Atrophy	Disease	MESH:D001284
33423870	1901	1905	mOFC	Disease	
33423870	1935	1942	atrophy	Disease	MESH:D001284
33423870	1979	1985	apathy	Disease	
33423870	1989	2009	cognitively impaired	Disease	MESH:D003072

